CurveBeam Connect: Radiology and Weight Bearing CT Imaging

In the lead-up to CurveBeam’s Annual User Meeting, initially planned for mid-October, 2022, CurveBeam Connect sat down with featured speaker Dr. Tom Turmezei, Ph.D., a consultant MSK Radiologist at Norfolk and Norwich University Hospital, UK. He joined host Vinti Singh to preview some of the great content he planned to share. (Note: The CurveBeam User Meeting has been postponed to Spring 2023.)

Dr. Turmezei is a founding member of the Computed Tomography in Osteoarthritis (OCTA) Research group.

He also serves as Radiology Representative on the Board for International Weight-Bearing CT Society.

Dr. Turmezei recently returned from Tokyo, where he presented his research at the 16th International Workshop on Osteoarthritis Imaging.

“What has been absolutely pleasing to see is weight bearing CT is forming a much larger part of the agenda,” Dr. Turmezei said.

Traditionally, MRI dominated radiology-led conversations at these types of meetings, but radiologists are beginning to embrace where CT and WBCT can provide unique insights, Dr. Turmezei said.

Dr. Turmezei’s own research has been focused on predictors for hip osteoarthritis, and CT has been helpful on identifying morphology characteristics that could point to who may need a hip replacement in the future.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…